73 A post hoc analysis suggested that a higher proportion of insulin-resistant patients in the phase 2 trial may have contributed to the discrepant results, because Exenatide PD3 showed a non-significant trend toward benefit only in the small insulin-resistant subgroup
That framing has been shifting: obesity is increasingly recognized as a chronic disease, one that responds to medication the way other chronic conditions do
10.14814/phy2.13852 [DOI] [PMC free article] [PubMed] [Google Scholar] Raz I., Fonseca V., Kipnes M., Durrwell L., Hoekstra J., Boldrin M., et al
[16] It is thought to enter the inner cytoplasmic membrane via a pH-dependent active transport system and afterward become chelate within the cytoplasm
The drips, cryo, and red light therapy are amazing